Home > Balance Sheet > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Net Current Assets

    Back to Balance Sheet
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

NATH BIOGENES (INDIA) Last 5 Year Net Current Assets History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Net Current Assets (Including Current Investments) ₹325 Cr₹309 Cr₹303 Cr₹273 Cr₹22 Cr

What is the latest Net Current Assets ratio of NATH BIOGENES (INDIA) ?

The latest Net Current Assets ratio of NATH BIOGENES (INDIA) is ₹325 Cr based on Mar2025 Consolidated results.
Year Net Current Assets
Mar2025₹325 Cr
Mar2024₹309 Cr
Mar2023₹303 Cr
Mar2022₹273 Cr
Mar2013₹22 Cr

How is Net Current Assets of NATH BIOGENES (INDIA) Trending?

Years Net Current Assets % Change
Mar2025 ₹325 Cr
5.01
Mar2024 ₹309 Cr
1.92
Mar2023 ₹303 Cr
10.94
Mar2022 ₹273 Cr
1,164.10
Mar2013 ₹22 Cr -

Compare Net Current Assets of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹317.3 Cr 11.9% 15.1% 17.3% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹10,480.4 Cr 3.9% -4.3% -14.1% Stock Analytics
KAVERI SEED COMPANY ₹4,735.7 Cr 1.5% 15% -29.6% Stock Analytics
VENKYS (INDIA) ₹2,148.4 Cr 4.4% 21.6% -8% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,072.7 Cr 5.4% 21.1% -14.5% Stock Analytics
INDO US BIOTECH ₹219.4 Cr 2.8% 10.5% -31.4% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

11.9%

15.1%

17.3%

SENSEX

0.6%

1.5%

6.6%


You may also like the below Video Courses